Surface Protein Technology for Wireless Diagnostic Applications.

Diagnostics, Telemedicine. Company provides surface protein technology that enhances the utility of diagnostic applications, via the integration of biological analysis and wireless technology. It is currently developing a miniature wireless platform enabling the reading of biological samples (i.e., swabs,...

Tissue Engineered Composite Implants.

Regenerative Medicine, Neurology, Cardiology. Company is developing advanced bioengineering solutions for nerve and blood vessel regeneration to address traumatic and degenerative diseases. The company’s lead products are composite implants that combine neuronal tissue culture and biocompatible tissue...

SEA Medical: Technology to Prevent Deadly IV Mistakes

Intravenous (IV) drugs leave a huge margin for human error, particularly at the point of administration. Patients can get the wrong solution, an incorrect dosage, or an overly rapid rate of delivery. The solution may have been formulated incorrectly. Over 4,000 deaths related to IV mistakes occur in the...

Defining a Radiation Target with Augmenix

Radiation therapy has one mission: to kill. Although its knack for destruction makes it an effective cancer treatment, organs that are located close to the tumor site may suffer as well. If there were a way to move organs apart during treatment, and to clearly identify remaining cancer cells following...

Streamlining the Stenting Process with Svelte Medical

Although tiny in size, stents rake in big money. There is an estimated $5 billion market for these small tubes that hold coronary arteries open during and after angioplasty. One company working to capture a share of this market is Svelte Medical Systems. Svelte was founded in 2007 by a father and...

IN3 West Is Almost Here

Register now to attend IN3 West, which takes place March 3-5 at the Venetian Hotel-Resort-Casino in Las Vegas. IN3 West brings together today’s brightest medical technology innovators with investors, venture capitalists, and business executives. Enjoy presentations from nearly 50 emerging companies,...

Nabi Tries to Help Smokers Break the Habit

“Quitting smoking” is one of the most popular New Year’s resolutions, right up there with “losing weight” and “exercising more.” Despite the promises, the patches and nicotine gum, only a small percentage manages to shake the addiction. The U.S. Centers for Disease...

Access Pharma (ACCP.OB) Product Development Update – Sponsored Post

Access Pharmaceuticals (OTC: ACCP.OB, “Access”) develops and commercializes products for the treatment and supportive care of cancer patients, including: - MuGard, an FDA-approved rinse for the management of patients with oral mucositis, a debilitating side effect of various cancer treatments -...